Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2677 |
|
| Actual shortage: | 255 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2413 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (9%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Resolved | 2023-11-03 | 2024-03-07 | 209122 |
| TEVA-IRBESARTAN HCTZ | 300MG 12.5MG | TABLET | Actual shortage | 2024-04-11 | 2024-04-11 | 224895 |
| TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Actual shortage | 2024-04-11 | 2024-04-18 | 224898 |
| TEVA-KETOCONAZOLE | 200MG | TABLET | Resolved | 2017-04-03 | 2017-09-06 | 5201 |
| TEVA-KETOCONAZOLE | 200MG | TABLET | Resolved | 2020-02-13 | 2020-04-09 | 106021 |
| TEVA-KETOCONAZOLE | 200MG | TABLET | Resolved | 2020-09-24 | 2020-11-07 | 124977 |
| TEVA-KETOCONAZOLE | 200MG | TABLET | Resolved | 2021-01-22 | 2021-09-02 | 132261 |
| TEVA-KETOCONAZOLE | 200MG | TABLET | Resolved | 2022-02-17 | 2022-05-26 | 155177 |
| TEVA-LACOSAMIDE | 100MG | TABLET | Resolved | 2019-09-26 | 2019-11-14 | 94831 |
| TEVA-LACOSAMIDE | 150MG | TABLET | Resolved | 2019-10-03 | 2019-10-10 | 95387 |
| TEVA-LACOSAMIDE | 50MG | TABLET | Resolved | 2019-12-05 | 2020-04-02 | 100296 |
| TEVA-LACOSAMIDE | 150MG | TABLET | Resolved | 2020-01-30 | 2020-04-02 | 104899 |
| TEVA-LACOSAMIDE | 100MG | TABLET | Resolved | 2020-03-19 | 2020-04-02 | 109050 |
| TEVA-LACOSAMIDE | 50MG | TABLET | Resolved | 2021-04-29 | 2021-06-24 | 138323 |
| TEVA-LACOSAMIDE | 100MG | TABLET | Resolved | 2021-06-03 | 2021-06-10 | 140399 |
| TEVA-LACOSAMIDE | 200MG | TABLET | Resolved | 2022-05-12 | 2022-05-26 | 160442 |
| TEVA-LACOSAMIDE | 150MG | TABLET | Resolved | 2023-06-08 | 2023-06-27 | 194194 |
| TEVA-LACOSAMIDE | 150MG | TABLET | Resolved | 2023-06-19 | 2023-06-27 | 195446 |
| TEVA-LACOSAMIDE | 50MG | TABLET | Actual shortage | 2024-03-18 | 2024-04-05 | 222575 |
| TEVA-LACTULOSE | 667MG | SOLUTION | Resolved | 2017-08-21 | 2017-10-10 | 19964 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106133 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65020 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65023 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | To be discontinued | 2019-07-05 | 2019-07-05 | 88619 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |